Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Durham VA Medical Center | FED |
| Boehringer Ingelheim | INDUSTRY |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The primary objective of this research project is to describe the characteristics, diagnosis, management, and outcomes of patients with Interstitial Lung Disease (ILD) who received care at the Veteran's Administration Veterans Integrated Service Network (VISN) 6 Mid-Atlantic Health Care Network (VISN6) (includes North Carolina, Virginia and West Virginia) for up to 5 years.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Interstitial Lung Disease | Patients will be identified from a specified 5 year period based on an International Classification of Diseases-9 (ICD-9) code diagnosis of Interstitial Lung disease (515) or Idiopathic Pulmonary Fibrosis (516.3). The patients will be obtained from the records of the Veterans Integrated Service Network (VISN) 6: VA Mid-Atlantic Health Care Network. |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Prevalence of Interstitial Lung Disease in the VISN6 Veterans Administration Patient Population | up to 5 years | |
| Prevalence of Idiopathic Pulmonary Fibrosis in the VISN6 Veterans Administration Patient Population | up to 5 years |
| Measure | Description | Time Frame |
|---|---|---|
| Accuracy of ICD-9 Codes for diagnosis of Interstitial Lung Disease | Will compare the reported ICD-9 code diagnosis with the diagnosis made after chart review and re-interpretation of the lung imaging and pathology | up to 5 years |
| Frequency of ICD-9 code diagnosis of Interstitial Lung Disease and clinic consultation with a pulmonary provider |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
All adults with encounters at any VISN6 healthcare facility during specified time period
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Robert M Tighe, MD | Duke University Department of Medicine and Durham VA Medical Center | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Durham VA Medical Center | Durham | North Carolina | 27705 | United States |
Not provided
| ID | Term |
|---|---|
| D017563 | Lung Diseases, Interstitial |
| D054990 | Idiopathic Pulmonary Fibrosis |
| ID | Term |
|---|---|
| D008171 | Lung Diseases |
| D012140 | Respiratory Tract Diseases |
| D011658 | Pulmonary Fibrosis |
Not provided
Not provided
Not provided
Not provided
Not provided
| up to 5 years |
| Prevalence of Co-morbid Diabetes Mellitus with Interstitial Lung Disease | Compare the prevalence of diabetes with interstitial lung disease as compared to the prevalence of diabetes in the general VA population | up to five years |